Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives

Patients with inflammatory bowel disease (IBD) face an increased lifetime risk of developing colorectal cancer (CRC). Independent factors associated with increased risk include long disease duration, extensive colonic involvement, young age at onset of IBD, severity of inflammation, primary sclerosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolfi, Carmine, Pallone, Francesco, Monteleone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373216/
https://www.ncbi.nlm.nih.gov/pubmed/22701310
http://dx.doi.org/10.1155/2012/980458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373216/
https://www.ncbi.nlm.nih.gov/pubmed/22701310
http://dx.doi.org/10.1155/2012/980458

Ejemplares similares